CareLink Express™ Mobile US vs Neuro Mapper

Transmit cardiac device data via mobile tablets for review and evaluation. Medtronic makes it easy and convenient for clinicians to obtain cardiac device data via a mobile tablet and transmit that data to a device specialist who can review and interpret the data quickly, allowing the clinician to provide timely and efficient care. CareLink Express Mobile can be used with any cardiac device that’s supported on the CareLink™ Network. CareLink Express has been shown to improve clinician and patient satisfaction in acute care settings.1 1 Bello D, et al. Remote monitoring via CareLink Express improves patient and physician satisfaction and reduces economic costs in acute care centers. Abstract. April 2015. The CareLink Express mobile app should be used by healthcare personnel only in a clinical or hospital environment. Steps: 1. Launch the app to the start screen. 2. The Patient Connector is paired one time using Bluetooth®*. 3. The Patient Connector is placed over the patient's cardiac device. 4. Cardiac device data is sent remotely for review. 5. Cardiac device data was successfully sent. Medtronic and the Medtronic logo are trademarks of Medtronic. ™*Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company. Medtronic 710 Medtronic Parkway Minneapolis, MN 55432-5604 USA Tel: 763.514.4000 Fax: 763.514.4879 medtronic.com Toll-free: 1.800.328.2518 (24-hour technical support for physicians and medical professionals) UC201701026 EN ©2016 Medtronic. Minneapolis, MN. All Rights Reserved. Printed in USA. 06/2016

Neuromapper allows for a more efficient and sophisticated multi-dimensional behavioral brain mapping. It contains multiple cognitive and sensory paradigms that were selected based on current practice, known brain behavioral correlates and from review of neuroimaging and clinical research. Neuromapper allows for customized stimulus selection tailored to the patient's ability level and it will record the patient's accuracy and other sensitive behavioral metrics during baseline testing and incorporate that data into the mapping session to provide a more individualized, tailored testing approach. Neuromapper, in its current form, contains paradigms designed to assess language, learning/memory, executive functions, and vision/neglect. Additional paradigms are being researched and designed and a research consortium is being established between the Medical College and other academic centers to continue testing and developing these paradigms and to answer other important research questions about functional localization and clinical mapping.